首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Effects of 0.5 apraclonidine on optic nerve head and peripapillary retinal blood flow
【2h】

Effects of 0.5 apraclonidine on optic nerve head and peripapillary retinal blood flow

机译:0.5%阿普拉可尼定对视神经乳头和视神经乳头视网膜血流的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIMS—To examine the effects of 0.5% apraclonidine on optic nerve head (ONH) and peripapillary retinal blood flow by scanning laser Doppler flowmetry (SLDF).
METHODS—ONH and peripapillary retinal blood flow of 17 healthy subjects were measured by SLDF before and 1 hour and 3 hours after unilateral administration of 0.5% apraclonidine. The fellow eyes were treated with balanced salt solution and the examiners were masked as to which eye was treated with apraclonidine. On each occasion, three scans were obtained and haemodynamic variables (volume, flow, and velocity) were analysed at eight locations, four in the neural rim and four in the peripapillary retina, avoiding ophthalmoscopically visible vessels. The statistical significance of changes from the baseline value of variables and the differences in the measured quantities between apraclonidine treated eyes and fellow eyes at each time point were evaluated using Wilcoxon signed rank test.
RESULTS—The intraocular pressure was reduced significantly in apraclonidine treated eyes by 15.0% (p=0.001) at 1 hour and 30.0% (p=0.000) at 3 hours after administration. In the volume, flow, or velocity of ONH and peripapillary retinal blood flow, there were no significant changes from the baseline values at 1 hour and 3 hours after apraclonidine administration in either apraclonidine treated eyes (p >0.4) or fellow eyes (p >0.2). Also, no significant differences were found in the measured quantities between apraclonidine treated eyes and fellow eyes at each time point (p >0.1).
CONCLUSION—A single dose of topical apraclonidine 0.5% in healthy subjects does not have adverse effects on the ONH and peripapillary retinal blood flow.

机译:目的:通过扫描激光多普勒血流仪(SLDF)检测0.5%的阿普拉可乐定对视神经乳头(ONH)和视乳头周围视网膜血流的影响。
方法:通过17位健康受试者的ONH和视乳头视网膜血流测量单侧施用0.5%阿普拉可乐定之前,之后1小时和3小时的SLDF。用平衡的盐溶液对另一只眼睛进行治疗,并对检查者进行遮盖,以了解哪只眼睛用过阿普拉可尼定治疗。在每种情况下,均进行了三次扫描,并在八个位置分析了血流动力学变量(体积,流量和速度),其中四个位于神经边缘,四个位于乳头周围视网膜,避免了在镜下可见的血管。使用Wilcoxon符号秩和检验评估了变量基线值变化的统计显着性以及在每个时间点使用阿普拉克力定治疗的眼睛与另一只眼睛之间的测量量差异。给药后1小时,阿普拉克隆定治疗的眼睛增加15.0%(p = 0.001),给药3小时后增加30.0%(p = 0.000)。在使用阿普拉克力定治疗的眼睛(p> 0.4)或另一只眼睛(p> 0.4)中,在服用阿普拉克力定后1小时和3小时,ONH和乳头周围视网膜血流的体积,流量或速度与基线值无明显变化0.2)。同样,在每个时间点,经阿普拉克力定治疗的眼睛与另一只眼睛之间的测量量也没有显着差异(p> 0.1)。
结论—健康受试者中单剂量局部应用​​阿克罗定定0.5%不会产生不良影响对ONH和乳头周围视网膜血流的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号